Stroke and late-onset Alzheimer's disease (AD) are risk factors for each other; the
comorbidity of these brain disorders in aging individuals represents a significant challenge …

Abstract Alzheimer's disease (AD), an age-dependent neurodegenerative disorder, is the
most prevalent neurodegenerative disease worldwide. The primary pathological hallmarks …

Abstract The APOE 2/3/4 polymorphism is the greatest genetic risk factor for Alzheimer's
disease (AD). This polymorphism is also associated with variation in plasma ApoE level; …

Introduction Plasma biomarkers—cost effective, non‐invasive indicators of Alzheimer's
disease (AD) and related disorders (ADRD)—have largely been studied in clinical research …

Background and Objectives The menopause transition is increasingly recognized as a time
of importance for women's brain health. A growing body of work indicates that the classic …

Background ApoE4, the most significant genetic risk factor for late-onset Alzheimer's disease
(AD), sequesters a pro-synaptogenic Reelin receptor, Apoer2, in the endosomal …

Importance Posttraumatic stress disorder (PTSD), cardiovascular disease (CVD), and
Alzheimer disease are major public health issues, particularly for women. The implications …

Alzheimer's Disease (AD) is one of the main neurodegenerative diseases worldwide.
Unfortunately, AD shares many similarities with other dementias at early stages, which …

Context Resveratrol (RV), a natural compound found in grapes, berries, and peanuts, has
been extensively studied for its potential in treating Alzheimer's disease (AD). RV has shown …

Alzheimer's disease is characterized by 2 pathological proteins, amyloid beta 42 and tau.
The majority of Alzheimer's disease cases in the population are sporadic and late-onset …